Vitamin D3 Supplements on semen parameters

To assess the effectiveness of vitamin D3 in improving sperm count, motility and morphology in subfertile men

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/028788

Enrollment

120

Registered

2020-11-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R69- Illness, unspecified

Interventions

Intervention1: vitamin D3 supplements: vitamin D3 tablets will be given to improve the sperm count,motility and morphology of sub fertile women. TABLET CHOLECALCIFEROL, 2500 IU will be given twice a d

Eligibility

Inclusion criteria

Inclusion criteria: 1 Men with low motility, morphology and sperm count ie) oligoasthenoteratozoospermia who are attending the OPD in the first setting for the treatment .(Low sperm count 2 Men with TSH and HBA1c normal levels (normal TSH 0.25-5uIU/ml, HBA1c- 4-6 % ) 3 Men with Normo Gonadotropic LH and FSH normal levels (normal LH level 1.1- 7.0 mIu/ml, FSH level 1.7-12.0 mIu/ml)

Exclusion criteria

Exclusion criteria: 1 Men with azospermia aspermia 2 Men with grade III or more varicocele 3 Men with history of testicular malignancy 4 Men who are using drugs including anti hypertensives, anti psychotics, anti depressants, anti epileptics and anti coagulants.

Design outcomes

Primary

Measure	Time frame
improvement seen in the level of sperm count and motilityTimepoint: 45 days	—

Secondary

Measure	Time frame
improvement seen in the level of sperm count and motilityTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDR Archana R

Saveetha College Of Nursing SIMATS

priyadheenadayalan@gmail.com8608459398

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026